Treatment of conditions associated with decreased nitric oxide bioavailability, including elevated arginase conditions
CA 2515929 C · Owner: Children'S Hospital & Research Center At Oakland · Inventors: Morris, Claudia R.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention features methods and compositions for treatment of conditions associated with decreased nitric oxide bioavailability such as a condition , associated with elevated arginase activity using an arginine-based therapy, including combination therapy with an arginase inhibitor and/or magnesium.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed February 13, 2004 and granted November 19, 2013. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended February 13, 2024.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by February 13, 2026.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.